The nasal route is increasingly being used for the delivery of drugs. The route offers many advantages over other routes such as its noninvasive nature, self-administration of the drug, reduction of pain and risk of infection associated with the injectable route. Self-administration also reduces the costs involved in the assisted administration of drugs. The route also avoids the first pass metabolism of drugs and is being considered for brain drug delivery due to its close association with the brain.
Other market driving factors of nasal drug delivery includes dosage reduction due to increased bioavailability and proportional reduction in side effects, growing efficacy of the route as drugs are absorbed easily from the nasal route and the development of advanced products such as metered dose pressurized containers which deliver a very precise dose. The growth of over the counter nasal drugs such as inhalers for common cold, and rhinitis is also driving the market since these advanced products also require nasal route of delivery. Off label use of symptomatic inhaler treatment is also an important market driver.
The market’s constraints include irritation of the nasal route and the low dose of a drug that can be delivered through other route of administration, low awareness and low penetration of healthcare services in poor parts of Africa. The market is consolidated and reflects an oligopolistic outlook with a few dominant players. This allows a premium to be charged on most products.
Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/2696
Major Key Players
- Novartis AG,
- Pfizer, Inc.,
- Merck & Co., Inc.,
- AptarGroup Inc.,
- Johnson & Johnson Services, Inc.,
- GlaxoSmithKline plc,
- Becton Dickson & Company
Intranasal drug delivery has been growing in popularity due to qualities of intranasal route of drug administration which includes its noninvasive nature that reduces pain and discomfort of drug administration. It also eliminates threat of infections associated with injectable and also enables self-administration of drug and the costs associated with assisted drug delivery. Other market driving factors for nasal drug delivery includes growth of over the counter nasal drugs such as inhalers for common cold, growing efficacy of the route due to development of drugs absorbed easily from the nasal route and the development of advanced products such as metered dose pressurized containers which delivers a very precise dose. Moreover the nasal route also avoids the first pass metabolism of drugs thereby reducing the dosage due to increased bioavailability. Dosage reduction leads to reduced costs and side effects of the drug. The nasal route is also being explored for drug delivery to the brain due to its close association with the brain. Another potential application is the delivery of protein based and drugs like interferon through the nasal route.
The restraints include higher costs of the treatment and the impact of the nasal conditions on the rate and extent of drug administration. The lack of awareness and comparative low popularity of the route along with the lower drug volume that can be administered restricts the use of this route and the market. The nasal drug delivery market reflects an oligopolistic outlook with a few dominant market players. Often there is a premium on the products and as such it is a high cost low volume market.
Test the market data and market information presented in more than 60 market data tables and figures spread over 84 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Nasal Drug Delivery Market Research Report – Forecast till 2022”.
Access Report Details @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696
Depending on geographic region, nasal drug delivery market is segmented into following countries which includes UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by Egypt. The Saudi Arabia market is also rising due to rising healthcare expenditure and growing per capita income of the people. Among the African nations Algeria seems to hold a huge potential. However the future market will be led by some parts of Africa due to large unmet needs and growing awareness of nasal route.
Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system the market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications the market is again segmented into rhinitis, congestion, vaccinations and others.
Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/2696
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
Browse Related Report
Global Migraine market information, by types (Episodic and Chronic), by treatment type (Preventive and Abortive), by drug class (Triptans, Ergots, and Others) – Forecast to 2022
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
+1 646 845 9312
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India